Home / Data / Women's Health Trial Tracker Women's Health Trial Tracker Women's Health Trial Tracker organizes records from ClinicalTrials.gov API v2 into a static table for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.
Records 5,000
Last changed 10/10/2026
Update schedule 55 1 * * * UTC
Coverage 05/26/2000–10/09/2026 Record Record Date Vuga Group Change Status Recency Days Research Attention Score Adipose Tissue and Polycystic Ovary Syndrome (PCOS)(EIFFEL) 12/10/2012 OBSERVATIONAL not-comparable 5,052.75 0 Evaluation of IVA (SE Femur Scans) to Identify Incomplete AFFs 12/11/2012 OBSERVATIONAL not-comparable 5,051.75 0 Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer 01/11/2013 INTERVENTIONAL not-comparable 5,020.75 0 Group Interventions for Breast Cancer Survivors 01/24/2013 INTERVENTIONAL not-comparable 5,007.75 0 Aldosterone & Sodium Regulation in Postural Tachycardia Syndrome - Screening 02/04/2013 INTERVENTIONAL not-comparable 4,996.75 0 Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma 02/11/2013 OBSERVATIONAL not-comparable 4,989.75 0 A Prospective Cohort Study Evaluating Risk of Local Recurrence Following Breast Conserving Surgery and Endocrine Therapy in Low Risk Luminal A Breast Cancer 02/15/2013 OBSERVATIONAL not-comparable 4,985.75 0 OTIS Cimzia Pregnancy Registry 02/22/2013 OBSERVATIONAL not-comparable 4,978.75 0 Nebulized or Inhaled Albuterol for Lymphangioleiomyomatosis 02/26/2013 INTERVENTIONAL not-comparable 4,974.75 0 Safety Study of Adding Everolimus to Adjuvant Hormone Therapy in Women With High Risk of Relapse, ER+ and HER2- Primary Breast Cancer, Free of Disease After Receiving at Least One Year of Adjuvant Hormone Therapy 03/06/2013 INTERVENTIONAL not-comparable 4,966.75 0 Reproductive Health Program in Patients With Cancer 03/07/2013 INTERVENTIONAL not-comparable 4,965.75 0 Elucidation of Breast Milk Composition and Structure Over the First Year of Lactation: UC Davis Lactation Study 03/22/2013 OBSERVATIONAL not-comparable 4,950.75 0 The Efficacy and Safety of the Postoperative Adjuvant Treatment in Patients With High-risk Stage I Endometrial Carcinoma 03/29/2013 INTERVENTIONAL not-comparable 4,943.75 0 The Safety of Ovarian Preservation in Stage IA Endometrial Carcinoma 03/29/2013 INTERVENTIONAL not-comparable 4,943.75 0 Survivorship Care Planning in Improving the Quality of Life in Breast Cancer Survivors 04/05/2013 INTERVENTIONAL not-comparable 4,936.75 0 A Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms (AIMSS) 04/05/2013 INTERVENTIONAL not-comparable 4,936.75 0 Prospective Data Bank Creation to Study Vaginal Conditions 04/11/2013 OBSERVATIONAL not-comparable 4,930.75 0 Breast Cancer Proteomics and Molecular Heterogeneity 04/25/2013 OBSERVATIONAL not-comparable 4,916.75 0 Assessing Reproductive Outcomes in Young Female Cancer Survivors Through a National Fertility Preservation Registry 04/30/2013 OBSERVATIONAL not-comparable 4,911.75 0 Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy. 05/03/2013 INTERVENTIONAL not-comparable 4,908.75 0 Ovarian Tissue Transplantation 06/06/2013 INTERVENTIONAL not-comparable 4,874.75 0 Study of LEE011, BYL719 and Letrozole in Advanced ER+ Breast Cancer 06/07/2013 INTERVENTIONAL not-comparable 4,873.75 0 Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery 06/07/2013 INTERVENTIONAL not-comparable 4,873.75 0 Olaparib Treatment in BRCA Mutated Ovarian Cancer Patients After Complete or Partial Response to Platinum Chemotherapy 06/11/2013 INTERVENTIONAL not-comparable 4,869.75 0 An Optimized Programming of Healthy Children (APPROACH) 07/10/2013 INTERVENTIONAL not-comparable 4,840.75 0 Metformin Hydrochloride in Preventing Breast Cancer in Patients With Atypical Hyperplasia or In Situ Breast Cancer 07/23/2013 INTERVENTIONAL not-comparable 4,827.75 0 Prophylactic Salpingectomy With Delayed Oophorectomy 07/25/2013 INTERVENTIONAL not-comparable 4,825.75 0 Randomized Controlled Trial to Assess Blockade of Voltage Gated Sodium Channels During Surgery in Operable Breast Cancer 08/05/2013 INTERVENTIONAL not-comparable 4,814.75 0 Partial Irradiation and Sequential vs. Concurrent Chemo Early Breast Cancer 08/26/2013 INTERVENTIONAL not-comparable 4,793.75 0 Supervised Aerobic Training During or After Chemotherapy for Operable Breast Cancer 09/17/2013 INTERVENTIONAL not-comparable 4,771.75 0 Endometriosis, Food Consumption and Fertility 09/20/2013 OBSERVATIONAL not-comparable 4,768.75 0 Assessment of Paclitaxel-Induced Neuropathy 09/30/2013 OBSERVATIONAL not-comparable 4,758.75 0 Muscle Fiber Fragment Treatment for Urinary Incontinence 09/30/2013 INTERVENTIONAL not-comparable 4,758.75 0 Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgery 10/01/2013 INTERVENTIONAL not-comparable 4,757.75 0 SWIFT: Study of Women, Infant Feeding and Type 2 Diabetes After GDM Pregnancy 10/22/2013 OBSERVATIONAL not-comparable 4,736.75 0 Surgery and Chemotherapy With or Without Chemotherapy After Surgery in Treating Patients With Ovarian, Fallopian Tube, Uterine, or Peritoneal Cancer 10/28/2013 INTERVENTIONAL not-comparable 4,730.75 0 A Pilot Study Testing a Noninvasive Cryolipolysis Device Versus a High Intensity Focused Ultrasound Device for Fat Reduction 11/05/2013 INTERVENTIONAL not-comparable 4,722.75 0 Predictive Clinical and Biological Parameters in Gynecological Cancer 11/06/2013 INTERVENTIONAL not-comparable 4,721.75 0 REVIVE: Replens Versus Intra-Vaginal Estrogen for the Treatment of Vaginal Dryness on Aromatase Inhibitor Therapy 11/14/2013 INTERVENTIONAL not-comparable 4,713.75 0 Brain Functional MRI in Older Women With Breast Cancer (Brain fMRI-BC) 11/25/2013 OBSERVATIONAL not-comparable 4,702.75 0 Fulvestrant +/- Akt Inhibition in Advanced Aromatase Inhibitor Resistant Breast Cancer 11/25/2013 INTERVENTIONAL not-comparable 4,702.75 0 Chronic Toxicities Related to Treatment in Patients With Localized Cancer 11/25/2013 INTERVENTIONAL not-comparable 4,702.75 0 FDG PET/CT in Breast Cancer Bone Mets 11/27/2013 OBSERVATIONAL not-comparable 4,700.75 0 Levobupivacaine and Lidocaine for Paravertebral Block Causes Greater Hemodynamic Oscillations Than Levobupivacaine 12/09/2013 INTERVENTIONAL not-comparable 4,688.75 0 Characterization of a Prospective Cohort of Women With PCOS 12/13/2013 OBSERVATIONAL not-comparable 4,684.75 0 Group Versus Individual Physiotherapy for Urinary Incontinence in Aging Women 01/20/2014 INTERVENTIONAL not-comparable 4,646.75 0 Biobehavioral and Sociodemographic Characteristics of Long Term Survivors of Ovarian Cancer 01/23/2014 OBSERVATIONAL not-comparable 4,643.75 0 TAILORx Tissue Bank 01/31/2014 OBSERVATIONAL not-comparable 4,635.75 0 Discovering the Antecedents of Rheumatoid Arthritis Flare 01/31/2014 OBSERVATIONAL not-comparable 4,635.75 0 A Study of LY2835219 (Abemaciclib) in Combination With Therapies for Breast Cancer That Has Spread 02/06/2014 INTERVENTIONAL not-comparable 4,629.75 0
Source U.S. National Library of Medicine, ClinicalTrials.gov API v2 · official record · retrieved 10/10/2026 · upstream last modified 10/10/2026
Licence United States government work; public domain unless the source record says otherwise. Source: U.S. National Library of Medicine
Required notice Study records are informational and do not provide diagnosis, treatment advice, or an assessment of individual risk. What we add We compute Vuga Group, Change Status, Recency Days, Research Attention Score using the documented compute method. · methodology